Syndrome News and Research

RSS

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Researchers estimated the risk and one-year burden of a set of pre-specified cardiovascular outcomes in a cohort of COVID-19-infected patients who survived the acute phase of illness.

9 Feb 2022

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Researchers investigated the dynamics and longevity of neutralizing antibody response up to 480 days after the onset of infection in convalescent COVID-19 patients.

9 Feb 2022

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

In a new study, researchers revealed that the nucleotide-binding oligomerization domain-like receptors or NOD-like receptors family pyrin domain containing 3 (NLRP3) inflammasome is activated by the exosomes from plasma in COVID-19.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

AI based home monitoring during COVID-19 pandemic

Researchers conducted an open, prospective pilot feasibility analysis through artificial intelligence (AI)-based platform to provide clinical decision support on COVID-19 outcomes.

9 Feb 2022

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Scientists have recently studied the duration of protection provided by mRNA-based COVID-19 vaccines against symptomatic omicron infection, and associated severity and mortality.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

The scientists tested samples collected from free-living and confined deer in Iowa to see if infection and subsequent transmission of SARS-CoV-2 in deer happens in nature.

9 Feb 2022

Danish study of long COVID in teens

As an aftermath of the extended lockdowns and social distancing restrictions, Coronavirus disease 2019 (COVID-19) has impacted the quality of life of children and adolescents worldwide, not only physically due to the infection, but also mentally. A high level of anxiety and depression has been reported among pediatric patients and adolescents, many of whom were deprived of social interaction with peers during the pandemic.

9 Feb 2022

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019.

9 Feb 2022

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

A study by researchers from the United Kingdom finds no difference in the protection offered by mRNA vaccine boosters against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) when comparing those that have received BioNTech/Pfizer vaccine as a primary course to those that have received Oxford/AstraZeneca.

8 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

Syndrome News and Research

Study suggests people with COVID-19 exhibit increased risks and 12-month burdens of incident cardiovascular diseases

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

AI based home monitoring during COVID-19 pandemic

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Danish study of long COVID in teens

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

The B and T cell responses to SARS-CoV-2

Swedish study shows fully vaccinated are protected against severe COVID-19

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

Comparison of school protocols under the high incidence conditions due to the Omicron variant

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News